ORIC Pharmaceuticals, Inc.
ORIC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33 | -$36 | -$30 | -$36 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $6 | $7 | $0 | $0 |
| Change in WC | $2 | -$1 | -$8 | $4 |
| Other Non-Cash | -$1 | -$1 | $5 | $4 |
| Operating Cash Flow | -$25 | -$31 | -$33 | -$28 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$166 | -$124 | -$65 | -$35 |
| Inv. Sales/Matur. | $55 | $48 | $88 | $78 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$111 | -$77 | $22 | $43 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $110 | $134 | $0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | $0 | $0 | $0 |
| Financing Cash Flow | $109 | $134 | $0 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$26 | $27 | -$10 | $15 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $76 | $50 | $59 | $44 |
| End Cash | $50 | $76 | $49 | $59 |
| Free Cash Flow | -$25 | -$31 | -$33 | -$28 |